Histrelin Implant Shortage
Last Updated: September 24, 2021
Status: Resolved
Products Affected - Description
-
- Vantas subcutaneous implant, Endo Pharmaceuticals, 50 mg, kit, NDC 67979-0500-01 - discontinued
Reason for the Shortage
-
- Endo discontinued Vantas in September 2021.
- Endo has Supprelin LA available.
Available Products
-
- Supprelin LA subcutaneous implant, Endo Pharmaceuticals, 50 mg, kit, NDC 67979-0002-01
Updated
Updated September 24, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 17, 2021 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.